Saintil Merline 4

4 · Symbotic Inc. · Filed Mar 13, 2026

AI-generated summary of this filing

Updated Mar 14, 2026

Symbotic (SYM) Director Saintil Merline Sells Shares

What Happened

Saintil Merline, a director of Symbotic, sold a total of 3,414 shares on March 11, 2026 in open-market/private-sale transactions. The filing reports 3,114 shares sold at $50.76 (proceeds $158,059) and 300 shares sold at $51.42 (proceeds $15,425), for aggregate proceeds of about $173,484. This was a sale (not a purchase) and thus generally not a bullish signal.

Key Details

Transaction dates and prices: March 11, 2026 — reported lots: 3,114 shares @ $50.76 and 300 shares @ $51.42. Footnotes state the sales were executed in multiple trades at price ranges $50.17–$51.16 and $51.18–$51.65, respectively; the reporting person will provide per-trade breakdown on request.
Plan/authorization: Executed pursuant to a Rule 10b5-1 trading plan entered August 27, 2025 (Footnote F1).
Shares owned after transaction: Not disclosed in the provided filing.
Filing timeliness: Form 4 filed March 13, 2026 for transactions on March 11, 2026 — appears timely (no late filing reported).

Context

Sales executed under 10b5-1 plans are pre-set and often indicate scheduled/automated disposals rather than discretionary insider decisions; they do not, by themselves, imply company outlook. For retail investors, purchases typically carry more direct informational weight than routine sales.

Form 4

Period: 2026-03-11

Director

Transactions

Sale
Class A Common Stock
[F1][F2]
2026-03-11$50.76/sh−3,114$158,059→ 75,644 total
Sale
Class A Common Stock
[F1][F3]
2026-03-11$51.42/sh−300$15,425→ 75,344 total

Footnotes (3)

[F1]This transaction was executed pursuant to a trading plan entered into by the Reporting Person on August 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
[F2]In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $50.17 to $51.16, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $51.18 to $51.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Signature

/s/ Corey Dufresne, Attorney-in-Fact for Merline Saintil|2026-03-13

1 file